Forma Therapeutics Holdings (FMTX) reported Q2 EPS of ($1.10), $0.11 worse than the analyst estimate of ($0.99). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .
Forma Therapeutics Holdings (FMTX) reported Q2 EPS of ($1.10), $0.11 worse than the analyst estimate of ($0.99). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .